Strategy&’s 2022 Global CDMO Study of Pharmaceutical Operations

How to gain a competitive advantage in a fast-changing pharmaceutical supply ecosystem.

The global Covid-19 pandemic as well as geopolitical tensions and trade restrictions have drawn attention to profound geographical, technical, and structural shifts in pharmaceutical supply chains. Treatments are increasingly produced by highly capable contract development and manufacturing organizations (CDMOs). As new, extraordinarily sophisticated, advanced therapies (ATx) emerge to complement traditional large and small molecule treatments, this trend looks set to deepen and accelerate. Today, CDMOs are targeting an increasingly attractive business segment, in which pure play CDMOs and other market participants are taking on a growing role.

Continue reading Strategy&’s 2022 Global CDMO Study of Pharmaceutical Operations

The Pharma Gamechanger

Happy to share the following Article of Chemie Pharma Innovation with you (German only): https://www.chemiepharma-innovation.ch/pharmaindustrie/der-pharma-gamechanger

Continue reading The Pharma Gamechanger

Webinar: How can ESG create value in the pharma industry?

ESG stands for ‘environmental, social and governance’ – without a doubt a global mega trend, and even more so in the post Covid-19 world.

During this webinar, we will look at how a strong ESG proposition can create value. In particular, we will illustrate the value creation process by providing a framework tailored to the pharma value chain to describe the various options.

Continue reading Webinar: How can ESG create value in the pharma industry?

WEBINAR – Pharma news: German court decision – Sale of drugs from a Swiss company and new EU requirements

Dear pharma members

Germany has recently published a court decision with major impact on the pharma supply chain (commercial and clinical) in the EU Member States:

Continue reading WEBINAR – Pharma news: German court decision – Sale of drugs from a Swiss company and new EU requirements

Webinar – After the Brexit deal: what you need to know and do next – 18 January, 9am

The Brexit transition period ended on 31 December 2020 and there is finally a deal between the United Kingdom and the European Union. However, many relevant practical questions for businesses remain open and still need to be resolved especially in the Pharma & Life Sciences sector.

Continue reading Webinar – After the Brexit deal: what you need to know and do next – 18 January, 9am

The impact of Brexit on Pharma, Life Science and MedTech companies – A PwC Pharma & Life Sciences Webinar

Dear pharma & life sciences colleagues

Brexit is coming closer every day with many aspects still unclear which makes it hard for you to prepare for it.

We’re excited to take a closer look at the current status quo and the impact of Brexit on indirect taxes, movement of goods and trade for Pharma, Life Sciences and MedTech Companies.

Continue reading The impact of Brexit on Pharma, Life Science and MedTech companies – A PwC Pharma & Life Sciences Webinar

PwC Pharma & Life Sciences Webinar: Keep up to date with regulatory developments

Dear pharma & life sciences colleagues,

As a tax/regulatory specialist within a pharmaceutical & life sciences company, you face complex sector-specific challenges each and every day.

You have to do more with fewer resources and find efficient and pragmatic solutions in line with rapidly changing local legislation.

Continue reading PwC Pharma & Life Sciences Webinar: Keep up to date with regulatory developments

PwC’s Pharma & Life Sciences Hot Topics 2020

The year 2020 has seen a lot of development in the way we do business such as new regulations and smarter solutions to solve old and new challenges. PwC has identified the following hot topics for Pharma & Life Sciences which need our special attention:

Continue reading PwC’s Pharma & Life Sciences Hot Topics 2020

Pharma & Life Sciences: 4 cutting edge digital tax & regulatory solutions

Discover PwC’s four cutting edge digital tax & regulatory solutions and how they can add value to your business, help you complying with new laws, stay up to date with upcoming changes in legislation and regulatory.

Continue reading Pharma & Life Sciences: 4 cutting edge digital tax & regulatory solutions

PwC Pharma & Life Sciences Webinar: COVID-19 impact on the ITX and regulatory DNA

Dear pharma & life sciences colleagues,

It was a pleasure to welcome you to our webinar: PwC Pharma & Life Sciences Webinar: COVID-19 impact on the ITX and regulatory DNA.

Attached below you can download the presentation.

Continue reading PwC Pharma & Life Sciences Webinar: COVID-19 impact on the ITX and regulatory DNA